Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Telix Pharmaceuticals has selected Goodwin Biotechnology to optimize the process for cGMP manufacturing of its renal cancer imaging antibody drug conjugate TLX-250.
read more
Wednesday, October 21, 2020
Teknova has completed the FDA notification process for its CDC formulation Viral Transport Medium.
read more
Wednesday, October 16, 2019
Tedor Pharma entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine.
read more
AssurX has announced that oral solid dose CDMO TEDOR Pharma has selected the AssurX platform to fully automate their quality and compliance management processes.
read more
TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures.
read more
Tuesday, October 15, 2019
Tedor Pharma announced they entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine’s triple combination drug product for the short-term treatment of transient insomnia.
read more
TCR2 Therapeutics has selected the advanced therapy medicinal products ecosystem in the United Kingdom (UK) to establish a site for global manufacturing systems and capabilities.
read more
Wednesday, March 31, 2021
TCR2 Therapeutics has signed a long-term, full-building lease with Alexandria Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.
read more
Monday, November 16, 2020
TCR2 Therapeutics has established a manufacturing partnership with ElevateBio, to leverage the technical capabilities at ElevateBio BaseCamp, a cell and gene therapy manufacturing facility based in Waltham, MA.
read more
Wednesday, February 19, 2020
TCP Reliable has undergone a corporate rebranding and is now officially Integreon Global.
read more
Thursday, November 05, 2020
Taysha Gene Therapies and Catalent announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Takara Bio announced the MPA has granted a manufacturing license for derivation and banking of human embryonic stem cells to be produced under GMP conditions within Takara Bio Europe's facility.
read more
Monday, September 28, 2020
T-knife GmbH and Catalent announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor program.
read more